ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 793,45
1,45%
DAX
18 518,03
-0,44%
Brent Oil
83,465
-1,04%
Bitcoin
64 386,15
-0,72%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Summit Therapeutics Inc (SMMT)

  7. Summit Therapeutics Inc (SMMT) Actualités

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateHeureSourceTitreSymboleSociété
21/04/202114h04GlobeNewswire Inc.Summit Therapeutics Announces Commencement of Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
31/03/202122h52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SMMTSummit Therapeutics Inc
26/03/202122h08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
26/03/202112h00GlobeNewswire Inc.Summit Therapeutics Announces Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
17/03/202112h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
17/03/202112h00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 202...NASDAQ:SMMTSummit Therapeutics Inc
02/03/202123h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
02/03/202123h35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SMMTSummit Therapeutics Inc
16/02/202113h33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SMMTSummit Therapeutics Inc
20/01/202122h37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:SMMTSummit Therapeutics Inc
20/01/202112h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SMMTSummit Therapeutics Inc
08/01/202115h08Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SMMTSummit Therapeutics Inc
23/11/202013h00GlobeNewswire Inc.Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating OfficerNASDAQ:SMMTSummit Therapeutics Inc
23/11/202012h02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SMMTSummit Therapeutics Inc
16/11/202022h05GlobeNewswire Inc.Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September ...NASDAQ:SMMTSummit Therapeutics Inc
06/11/202022h01GlobeNewswire Inc.Summit Announces Closing of Private Placement of $50 MillionNASDAQ:SMMTSummit Therapeutics Inc
05/10/202022h31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SMMTSummit Therapeutics Inc
05/10/202022h28Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SMMTSummit Therapeutics Inc
03/10/202000h40GlobeNewswire Inc.Summit Announces Agreement For a Fundraising of approximately $50 MillionNASDAQ:SMMTSummit Therapeutics Inc
29/09/202013h00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2...NASDAQ:SMMTSummit Therapeutics Inc
28/09/202022h41Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:SMMTSummit Therapeutics Inc
18/09/202022h11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:SMMTSummit Therapeutics Inc
18/09/202015h25Edgar (US Regulatory)Notification That a Class of Securities of Successor Issuer Is Demed to Be Registered Pursuant to Section 12(b) (8-k12b)NASDAQ:SMMTSummit Therapeutics Inc
18/09/202013h10GlobeNewswire Inc.Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USANASDAQ:SMMTSummit Therapeutics Inc
17/09/202013h32Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
17/09/202013h00GlobeNewswire Inc.Summit Therapeutics Announces U.K. Court Approval of SchemeNASDAQ:SMMTSummit Therapeutics Inc
19/08/202022h01GlobeNewswire Inc.Summit Announces Results of Court Meeting and General MeetingNASDAQ:SMMTSummit Therapeutics Inc
16/07/202013h00GlobeNewswire Inc.Summit Announces Intention to Redomicile its Holding Company to the United StatesNASDAQ:SMMTSummit Therapeutics Inc
13/07/202013h00GlobeNewswire Inc.Summit Announces Publication of Phase 2 Clinical Analyses of Gut Microbiome HealthNASDAQ:SMMTSummit Therapeutics Inc
08/06/202013h00GlobeNewswire Inc.Summit Appoints Michael Donaldson as Chief Financial OfficerNASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT

Dernières Valeurs Consultées

BIT
UC6M1W
Unicredit Bank
LSE
0AZR
Estoril Sol Sgps
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés